全文获取类型
收费全文 | 467篇 |
免费 | 30篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 5篇 |
妇产科学 | 12篇 |
基础医学 | 39篇 |
口腔科学 | 9篇 |
临床医学 | 64篇 |
内科学 | 55篇 |
皮肤病学 | 11篇 |
神经病学 | 26篇 |
特种医学 | 4篇 |
外科学 | 28篇 |
综合类 | 16篇 |
预防医学 | 106篇 |
眼科学 | 2篇 |
药学 | 32篇 |
中国医学 | 4篇 |
肿瘤学 | 78篇 |
出版年
2022年 | 12篇 |
2021年 | 11篇 |
2020年 | 9篇 |
2019年 | 10篇 |
2018年 | 30篇 |
2017年 | 13篇 |
2016年 | 18篇 |
2015年 | 14篇 |
2014年 | 14篇 |
2013年 | 55篇 |
2012年 | 41篇 |
2011年 | 49篇 |
2010年 | 20篇 |
2009年 | 17篇 |
2008年 | 16篇 |
2007年 | 19篇 |
2006年 | 16篇 |
2005年 | 20篇 |
2004年 | 11篇 |
2003年 | 17篇 |
2002年 | 20篇 |
2001年 | 11篇 |
2000年 | 2篇 |
1999年 | 3篇 |
1998年 | 5篇 |
1997年 | 1篇 |
1996年 | 4篇 |
1995年 | 6篇 |
1994年 | 3篇 |
1993年 | 5篇 |
1992年 | 5篇 |
1991年 | 1篇 |
1990年 | 3篇 |
1989年 | 2篇 |
1988年 | 4篇 |
1987年 | 1篇 |
1984年 | 1篇 |
1983年 | 2篇 |
1982年 | 2篇 |
1980年 | 2篇 |
1979年 | 2篇 |
排序方式: 共有497条查询结果,搜索用时 15 毫秒
1.
Status,challenges and facilitators of consumer involvement in Australian health and medical research
Background
The emergent international practice of involving consumers in health research is driven, in part, by the growing share of health research that can only be applied in and emerge from knowledge that is shaped by human values and societal contexts. This is the first investigation of its kind to identify the current prevalence, challenges, enabling factors and range of approaches to consumer involvement in health and medical research in Australia. 相似文献2.
3.
4.
Afaf Y. Khormi Thoraya. A. Farghaly Abrar Bayazeed Youssef O. Al-Ghamdi Hanan Gaber Abdulwahab Mohamed R. Shaaban 《RSC advances》2022,12(42):27355
Novel thiazole derivatives possessing phenyl sulfonyl moiety were designed and synthesized as B-RAFV600E kinase inhibitors based on the clinically-approved anticancer drug, dabrafenib. All target compounds showed significant inhibition of B-RAFV600E kinase enzyme at nanomolar levels. Compounds 7b and 13a revealed excellent B-RAFV600E inhibitory activity, superior to that of dabrafenib with IC50 values of 36.3 ± 1.9, 23.1 ± 1.2, and 47.2 ± 2.5 nM, respectively. Moreover, the title compounds were much more selective toward B-RAFV600E kinase than B-RAF wild type. In addition, the most potent compounds were further evaluated for their anticancer activity against B-RAFV600E-mutated and wild type melanoma cells. A positive correlation between the cytotoxic activity and selectivity for B-RAF V600E over B-RAF wild type was clearly observed for compounds 7b, 11c, 13a, and 17. All the screened compounds potently inhibited the growth of WM266.4 melanoma cells with IC50 values in the range from 1.24 to 17.1 μM relative to dabrafenib (IC50 = 16.5 ± 0.91 μM). Compounds 7b, 11a and 11c, 13a, and 17 were much more potent than dabrafenib against B-RAFV600E-mutated WM266.4 melanoma cells. Furthermore, compound 7b suppressed the phosphorylation of downstream ERK1/2 from WM266.4 cells. Also, the docking study revealed the proper orientation and well-fitting of the title compounds into the ATP binding site of B-RAFV600E kinase.Thiazole derivatives 7b and 13a were superior to dabrafenib against B-RAFV600E kinase and potently inhibited the growth of WM266.4 melanoma cells. Compound 7b suppressed the phosphorylation of downstream ERK1/2 from WM266.4 cells. 相似文献
5.
Geir Bjørklund Nagwa A. Meguid Afaf El-Ansary Mona A. El-Bana Maryam Dadar Jan Aaseth Maha Hemimi Joško Osredkar Salvatore Chirumbolo 《Journal of molecular neuroscience : MN》2018,66(4):492-511
Autism spectrum disorder (ASD) is a neurodevelopmental disorder afflicting about one in every 68 children. It is behaviorally diagnosed based on a triad of symptoms, including impairment in communication, impairment in sociability and abnormal and stereotypic behavior. The subjectivity of behavioral diagnosis urges the need for clinical biomarker tests to improve and complement ASD diagnosis and treatment. Over the past two decades, researchers garnered a broad range of biomarkers associated with ASD and often correlating with the severity of ASD, which includes metabolic and genetic biomarkers or neuroimaging abnormalities. Metabolic biomarkers are either involved in key pathways such as a trans-sulfuration pathway or produced due to the derangement of these pathways in the case of oxidative stress. Recent studies reported several genetic abnormalities related to ASD, encompassing various mechanisms, from copy number variations (CNVs) and single nucleotide polymorphisms (SNPs) to chromosomal anomalies. However, it is still premature to consider these genetic variants as true biomarkers for ASD, due to their low reproducibility and regional-specific nature. Herein, we comprehensively review state of the art about major biomarkers reported in ASD and the association of some biomarkers with ASD symptoms and severity. It is important to establish those biomarkers to be able to help in the diagnosis and to optimize the treatment of ASD. 相似文献
6.
Laila Y Al- Ayadhi Abir G Ben Bacha Malak Kotb Afaf K El-Ansary 《Behavioral and brain functions : BBF》2012,8(1):4
Objectives
We examined whether plasma concentrations of amyloid beta (Aβ) as protein derivatives play a central role in the etiology of autistic features. 相似文献7.
8.
9.
10.